PKD和支架NHERF1在3T3-L1脂肪细胞中介于缺氧诱导的基因表达
Ying-Yu Wu1,2, Yu-Yao Huang3, Juu-Chin Lu1,2,3
1Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Journal of molecular endocrinology
|August 13, 2025
概括
蛋白质激酶D (PKD) 异型通过一种新的NHERF1-PKD1-HDAC5通路调节缺氧诱导因子1α (HIF1α) 稳定性,从而调节缺氧诱导的脂肪细胞功能障碍,影响肥胖研究.
科学领域:
- 细胞生物学 细胞生物学
- 疾病的分子机制.
- 肥胖问题研究研究
背景情况:
- 缺氧是脂肪细胞功能障碍和肥胖的一个已知的因素.
- 蛋白质激酶D 1 (PKD1) 有助于饮食诱导的脂肪.
- 在缺氧诱导的脂肪细胞功能障碍中,PKD异型的作用需要阐明.
研究的目的:
- 为了研究蛋白质激酶D (PKD) 异型在调解3T3-L1脂肪细胞中缺氧诱导的功能障碍中的作用.
- 阐明PKD在低氧条件下调节低氧诱导因子1α (HIF1α) 的分子机制.
主要方法:
- 使用的3T3-L1脂肪细胞暴露在缺氧条件下.
- 采用了包括西式涂抹,siRNA介导的枯竭和共免疫沉在内的技术.
- 研究了蛋白质酸化,蛋白质-蛋白质相互作用和亚细胞局部化.
主要成果:
- 低氧激活了PKD1,导致S916.6的酸化增加.
- PKD异型 (PKD1和PKD2) 调节了缺氧诱导的HIF1α积累和基因表达.
- 确定了一种涉及Na+/H+交换器调节因子1 (NHERF1),PKD1和基因素脱乙酶5 (HDAC5) 的新途径,通过HSP70乙化和HSP90关联调节HIF1α稳定性.
结论:
- PKD异型,特别是PKD1和PKD2,是低氧诱导的脂肪细胞功能障碍的关键调解者.
- 在低氧下,NHERF1-PKD1-HDAC5轴在稳定HIF1α中起着关键作用.
- 这项研究揭示了一种新的分子机制,该机制将低氧,脂肪细胞功能和肥胖病原体联系起来.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Cell Specific Gene Expression
13.9K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K


